Related Experiment Video
Updated: May 3, 2026

08:26
Comparative Analysis of Lower Limb Kinematics between the Initial and Terminal Phase of 5km Treadmill Running
Published on: July 17, 2020
5.3K
Advanced adenomas among young endurance runners: A prospective hypothesis-generating prevalence study
Whitney R Swain1, Selena Bonomelli1, Laura Johnston1
1Inova Schar Cancer Institute, 8081 Innovation Park Drive, Fairfax, VA 22031, USA.
Cancer Epidemiology
|May 1, 2026
Summary
Extreme endurance running may increase colorectal neoplasia risk. This study found advanced adenomas in 15% of runners, a potentially higher prevalence than in average-risk adults, warranting further research.
Area of Science:
- Gastroenterology
- Sports Medicine
- Oncology
Background:
- Extreme long-distance running causes gastrointestinal stress, including reduced blood flow and mucosal injury.
- The link between endurance running and colorectal neoplasia remains unclear.
- Rectal bleeding is a known post-exercise symptom in runners.
Purpose of the Study:
- To prospectively estimate the prevalence of advanced adenomas in endurance runners aged 35-50.
- To compare this prevalence with historical screening data in average-risk adults.
- To generate hypotheses regarding colorectal neoplasia risk in endurance athletes.
Main Methods:
- A prospective, single-center, cross-sectional study involving 94 endurance runners who completed at least two ultramarathons or five marathons.
- Participants underwent colonoscopy after completing a questionnaire.
- Advanced adenomas were defined by size (≥10 mm), histology (villous/tubulovillous, >25% villous), or high-grade dysplasia.
Main Results:
- Adenomas were detected in 41.5% of participants, with advanced adenomas found in 15.0% (95% CI, 8.4-23.7%).
- No colorectal cancers were detected in the study cohort.
- The prevalence of advanced adenomas appeared higher than the 1.2% historical rate in average-risk adults aged 40-49.
Conclusions:
- Advanced adenomas were found in 15.0% of the endurance runner sample.
- The observed prevalence suggests a potentially elevated risk of colorectal neoplasia in endurance runners compared to historical benchmarks.
- Further controlled studies are necessary to confirm these findings and investigate underlying mechanisms.

